Edition:
India

AB Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

4.23EUR
23 Aug 2019
Change (% chg)

€-0.07 (-1.63%)
Prev Close
€4.30
Open
€4.30
Day's High
€4.30
Day's Low
€4.22
Volume
26,665
Avg. Vol
72,237
52-wk High
€5.38
52-wk Low
€3.10

About

AB Science SA, also known as AB Science, is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer,... (more)

Overall

Beta: 1.19
Market Cap(Mil.): €177.84
Shares Outstanding(Mil.): 40.79
Dividend: --
Yield (%): --

Financials

  ABS.PA Industry Sector
P/E (TTM): -- 29.73 33.85
EPS (TTM): -0.69 -- --
ROI: -148.17 13.04 12.69
ROE: -- 14.12 17.13

BRIEF-AB Science: Positive Recommendation Of IDMC Following Interim Analysis Of Study AB12005

* ANNOUNCED ON WEDNESDAY POSITIVE RECOMMENDATION OF THE INDEPENDENT DATA MONITORING COMMITTEE (IDMC), FOLLOWING INTERIM ANALYSIS OF STUDY AB12005 IN THE FIRST-LINE TREATMENT OF PANCREATIC CANCER

13 Jun 2019

BRIEF-AB Science Presents New Preclinical Data For Masitinib In ALS

* ANNOUNCED ON TUESDAY NEW PRECLINICAL DATA FOR MASITINIB IN ALS AT 2019 MUSCULAR DYSTROPHY ASSOCIATION CONFERENCE

17 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates